$ALVR 90 DAYS STOCK PRICE FORECAST
Stock Price
About the Company
AlloVir is a leading late clinical-stage cell therapy company with a focus on restoring natural immunity against life-threatening viral diseases in patients with severely weakened immune systems. The company’s innovative and proprietary technology platforms leverage off-the-shelf, allogeneic, multi-virus specific T cells targeting devastating viruses for patients with T cell deficiencies who are at risk from the life-threatening consequences of viral diseases. AlloVir’s technology and manufacturing process enables the potential for the treatment and prevention of a spectrum of devastating viruses with each single allogeneic cell therapy. The company is advancing multiple mid- and late-stage clinical trials across its product portfolio.
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology
Employees
53
Similar Companies
| Name | Ticker | Market Capitalization (USD M) | Revenue (USD M) | Price/Book | Price/Earning | Net Margin (%) |
|---|---|---|---|---|---|---|
| Charles River Laboratories Int | CRL | 21115 | 3273 | 9.00 | 53.28 | 12.10 |
| Exact Sciences Corp. | EXAS | 15524 | 1712 | 4.63 | -17.52 | -49.89 |
| PRA Health Sciences Inc | PRAH | 10739 | 3333 | 6.88 | 50.52 | 6.40 |
| Syneos Health Inc | SYNH | 9147 | 4730 | 2.78 | 38.89 | 4.99 |
| Medpace Holdings Inc | MEDP | 7055 | 1028 | 7.81 | 40.02 | 17.02 |
| Exelixis Inc | EXEL | 6902 | 1157 | 3.31 | 74.14 | 8.13 |
| Twist Bioscience Corp | TWST | 5634 | 127 | 9.68 | -42.81 | -106.59 |
| Allakos Inc | ALLK | 5438 | 9.89 | -27.30 | None | |
| Vir Biotechnology Inc | VIR | 5162 | 183 | 7.14 | -17.02 | -162.74 |
| Sana Biotechnology Inc | SANA | 3669 | 4.21 | -11.20 | None | |
| Recursion Pharmaceuticals Inc | RXRX | 3242 | 9 | 5.07 | -26.44 | None |
| Lyell Immunopharma Inc | LYEL | 3126 | 8 | 3.06 | -16.15 | None |
| Instil Bio Inc | TIL | 2312 | 0 | 3.63 | -28.00 | None |
| Alx Oncology Holdings Inc | ALXO | 2166 | 1 | 5.39 | -18.67 | -401.23 |
| Verve Therapeutics Inc | VERV | 2083 | 5.13 | -21.06 | None | |
| Allogene Therapeutics Inc | ALLO | 2062 | 38 | 2.19 | -8.60 | -621.84 |
| Erasca Inc | ERAS | 2055 | -14.41 | -16.25 | None | |
| Sorrento Therapeutics Inc | SRNE | 1840 | 51 | 11.05 | -5.81 | -626.43 |
| Cortexyme Inc | CRTX | 1710 | 11.90 | -19.39 | None | |
| Constellation Pharmaceuticals | CNST | 1564 | 4.32 | -11.18 | None | |
| Castle Biosciences Inc | CSTL | 1554 | 78 | 4.09 | -66.91 | -28.88 |
| Pandion Therapeutics Inc | PAND | 1501 | 1069 | 1.83 | -13.34 | -10.55 |
| AlloVir Inc | ALVR | 1480 | 0 | 5.06 | -12.56 | -718.59 |
| Replimune Group Inc | REPL | 1458 | 2.91 | -16.17 | None | |
| Organogenesis Holdings Inc | ORGO | 1372 | 433 | 7.83 | 18.15 | 16.17 |
| Rubius Therapeutics Inc | RUBY | 1330 | 5.45 | -7.67 | None | |
| Y-Mabs Therapeutics Inc | YMAB | 1138 | 37 | 4.92 | -24.73 | -114.04 |
| National Research Corp | NRC | 1129 | 140 | 14.47 | 31.01 | 25.62 |
| Caribou Biosciences Inc | CRBU | 1098 | 5 | -24.96 | -21.71 | -955.31 |
| Century Therapeutics Inc | IPSC | 1076 | 2.42 | -15.44 | None | |
| Monte Rosa Therapeutics Inc | GLUE | 1016 | 2.94 | -17.64 | None | |
| Cullinan Oncology Inc | CGEM | 946 | 19 | 2.06 | -17.35 | -284.59 |
| Scholar Rock Holding Corp | SRRK | 901 | 16 | 4.21 | -8.33 | -687.82 |
| Precigen Inc | PGEN | 898 | 101 | 6.34 | -8.13 | -107.45 |
| Janux Therapeutics Inc | JANX | 882 | 1 | 2.33 | -76.82 | -436.67 |
| RAPT Therapeutics Inc | RAPT | 803 | 5 | 4.35 | -13.37 | 7.14 |
| Sutro Biopharma Inc | STRO | 792 | 69 | 2.83 | -8.69 | -114.69 |
| Imago BioSciences Inc | IMGO | 776 | -9.97 | -29.79 | None | |
| Design Therapeutics Inc | DSGN | 765 | 0 | 1.91 | -39.74 | -245.44 |
| MeiraGTx Holdings plc | MGTX | 723 | 19 | 3.80 | -12.51 | -325.95 |
| Graphite Bio Inc | GRPH | 718 | 1.96 | -14.58 | None | |
| Ideaya Biosciences Inc | IDYA | 709 | 36 | 3.65 | -27.21 | -84.49 |
| Crinetics Pharmaceuticals Inc | CRNX | 693 | 0 | 3.99 | -7.81 | -447.78 |
| Talaris Therapeutics Inc | TALS | 646 | 2.43 | -18.98 | None | |
| Precision Biosciences Inc | DTIL | 547 | 101 | 5.78 | -10.98 | -45.88 |
| Vor Biopharma Inc | VOR | 546 | 2.19 | -8.34 | None | |
| Rallybio Corp | RLYB | 526 | 38 | -7.86 | -12.39 | -1.07 |
| Acumen Pharmaceuticals Inc | ABOS | 525 | 1 | -5.14 | -5.41 | -550.91 |
| Mirum Pharmaceuticals Inc | MIRM | 463 | 11 | 5.26 | -3.04 | None |
| Werewolf Therapeutics Inc | HOWL | 457 | 2.47 | -2.45 | None | |
| Kezar Life Sciences Inc | KZR | 449 | 3.26 | -9.36 | None | |
| Applied Therapeutics Inc | APLT | 430 | 14 | 3.84 | -3.77 | -19.41 |
| Evelo Biosciences Inc | EVLO | 401 | 7.05 | -3.79 | None | |
| Cue Biopharma Inc | CUE | 367 | 5 | 5.30 | -8.50 | -802.84 |
| Oyster Point Pharma Inc | OYST | 360 | 2.38 | -4.51 | None | |
| Vera Therapeutics Inc | VERA | 355 | 3.91 | -6.48 | None | |
| Biomea Fusion Inc | BMEA | 340 | 1.68 | -18.06 | None | |
| Sera Prognostics Inc | SERA | 335 | 0 | -2.33 | -14.21 | None |
| Surface Oncology Inc | SURF | 329 | 90 | 2.35 | 14.71 | 18.99 |
| Aerovate Therapeutics Inc | AVTE | 328 | -16.22 | -22.30 | None | |
| Magenta Therapeutics Inc | MGTA | 325 | 1.88 | -4.68 | None | |
| Cabaletta Bio Inc | CABA | 312 | 3.20 | -8.02 | None | |
| Luna Innovations Inc | LUNA | 299 | 101 | 3.70 | 129.57 | 2.46 |
| Black Diamond Therapeutics Inc | BDTX | 278 | 1.12 | -2.65 | None | |
| INmune Bio Inc | INMB | 256 | 0 | 7.54 | -13.13 | None |
| Pieris Pharmaceuticals Inc | PIRS | 253 | 24 | 6.35 | -5.23 | -203.73 |
| Compass Therapeutics Inc | CMPX | 253 | 8.68 | -3.11 | None | |
| Candel Therapeutics Inc | CADL | 247 | 0 | -6.58 | -7.10 | None |
| Nextcure Inc | NXTC | 241 | 22 | 0.90 | -3.56 | -163.57 |
| Sensei Biotherapeutics Inc | SNSE | 218 | 1.32 | -7.63 | None | |
| AquaBounty Technologies Inc | AQB | 216 | 0 | 1.23 | -10.59 | None |
| Gemini Therapeutics Inc | GMTX | 211 | 1088 | 0.23 | 1.74 | 11.24 |
| Alzamend Neuro Inc | ALZN | 197 | 12.61 | -32.43 | None | |
| Impel NeuroPharma Inc. | IMPL | 181 | 3.62 | -3.73 | None | |
| Elevation Oncology Inc | ELEV | 179 | 1.16 | -8.02 | None | |
| Tscan Therapeutics Inc | TCRX | 174 | 6 | -2.90 | -5.07 | -563.14 |
| Hookipa Pharma Inc | HOOK | 152 | 20 | 1.20 | -2.48 | -304.07 |
| Reneo Pharmaceuticals Inc | RPHM | 151 | 0.92 | -5.54 | None | |
| Unity Biotechnology Inc | UBX | 124 | 1 | 1.93 | -1.53 | None |
| IN8bio Inc | INAB | 112 | -5.24 | -11.17 | None | |
| HCW Biologics Inc | HCWB | 109 | 4 | -4.95 | -16.95 | -162.03 |
| Exicure Inc | XCUR | 104 | 4 | 2.81 | -2.19 | -148.49 |
| Axcella Health Inc | AXLA | 103 | 2700 | 2.21 | -1.84 | -10.84 |
| Cyclerion Therapeutics Inc | CYCN | 90 | 4 | 1.76 | -1.34 | None |
| BioVie Inc | BIVI | 72 | 29.90 | -0.40 | None | |
| Scopus Biopharma Inc | SCPS | 70 | 234 | -35.55 | -3.34 | 80.93 |
| Eloxx Pharmaceuticals Inc | ELOX | 70 | 0 | 3.17 | -1.28 | -14.14 |
| Synaptogenix Inc | SNPX | 65 | 2.05 | -4.31 | None | |
| Monopar Therapeutics Inc | MNPR | 60 | 2.68 | -7.56 | None | |
| NanoViricides Inc | NNVC | 54 | 1.88 | -6.05 | None | |
| CohBar Inc | CWBR | 53 | 4.84 | -3.17 | None | |
| Rezolute Inc | RZLT | 53 | 3.91 | -2.43 | None | |
| Acurx Pharmaceuticals Inc | ACXP | 48 | 3.14 | -6.00 | None | |
| Vaccinex Inc | VCNX | 47 | 1 | 3.53 | -1.66 | -48.71 |
| Cyclo Therapeutics Inc | CYTH | 39 | 1 | 3.77 | -1.86 | -989.80 |
| TransCode Therapeutics Inc | RNAZ | 38 | -8.08 | -10.86 | None | |
| Unicycive Therapeutics Inc | UNCY | 36 | 113 | -8.79 | -9.81 | 7.94 |
| AgeX Therapeutics Inc | AGE | 35 | 2 | -4.18 | -3.68 | -522.77 |
| Aridis Pharmaceuticals Inc | ARDS | 35 | 0 | -3.79 | -1.40 | -851.00 |
| Cytocom Inc | CBLI | 30 | 0 | 3.88 | -12.72 | -912.16 |
| Tenax Therapeutics Inc | TENX | 18 | 0 | 27.83 | -0.71 | -840.64 |
| Geovax Labs Inc | GOVX | 16 | 1 | 1.30 | -11.11 | -558.09 |
| Kiromic BioPharma Inc | KRBP | 15 | 6.91 | -1.10 | None | |
| Xenetic Biosciences Inc | XBIO | 14 | 1 | 1.73 | -1.07 | -47.40 |
| Neurotrope Inc | NTRP | 5 | 29 | 0.08 | 0.76 | 23.48 |
33 Stocks Moving In Tuesday's Mid-Day Session
Gainers HCW Biologics Inc. (NASDAQ: HCWB) surged 31% to $3.75. Kaival Brands Innovations Group, Inc. (NASDAQ: KAVL) jumped 28 ...
AlloVir, Inc.: Creating Solutions For Stem Cell Transplant Issues
Upon the IPO issuance on August 3, 2020, the ElevateBio preferred shares converted to 39,859,139 shares of AlloVir, Inc. Thus, giving ElevateBio a controlling interest in AlloVir. At the time ...
AlloVir (NASDAQ:ALVR) Target Raised by Morgan Stanley to $48.00
Moving Average Technical Analysis 5 day Moving Average is $$22.64 And 5 day price change is -$0.26 (-1.14%) with average ...
Companies Like AlloVir (NASDAQ:ALVR) Are In A Position To Invest In Growth
Given this risk, we thought we'd take a look at whether AlloVir (NASDAQ:ALVR) shareholders should be worried about its cash burn. For the purposes of this article, cash burn is the annual rate at ...
FDA Grants Orphan Drug Designation (ODD) to AlloVir’s Posoleucel, an Allogeneic, Off-the-Shelf, Multi-Virus Specific T-Cell Therapy, for the Treatment of Virus-Associated ...
CAMBRIDGE, Mass.--(BUSINESS WIRE)--AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan ...
AlloVir Inc Ordinary Shares ALVR
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions.
AlloVir Hemorrhagic-Cystitis Drug Given Orphan Designation
AlloVir Inc.'s candidate drug to treat virus-associated hemorrhagic cystitis, posoleucel, has been granted orphan-drug designation by the U.S. Food and Drug Administration, AlloVir said Monday.
AlloVir, Inc. (ALVR)
October 04, 2021--AlloVir, Inc. (Nasdaq: ALVR), a late clinical-stage cell therapy company, today announced that the U.S. Food and Drug Administration (FDA) has granted Orphan Drug Designation ...
Brothers Who Made Billions on Pharma Firm Boost Health Bets
That includes almost $100 million in Cambridge, Massachusetts-based cell therapy companies ElevateBio and AlloVir Inc., according to a regulatory filing by Nogra Group. The Luxembourg-based firm ...
Is Arcos Dorados Holding Inc (ARCO) A Good Stock To Buy?
Let's now review hedge fund activity in other stocks - not necessarily in the same industry as Arcos Dorados Holding Inc (NYSE:ARCO) but similarly valued. We will take a look at AlloVir ...